Cite

HARVARD Citation

    Ferro, M. et al. (n.d.). PO-0625: Accelerated-hypofractionated IMRT plus Temozolomide in Glioblastoma:a phase I dose-escalation study. Radiotherapy and oncology. pp. S327-. [Online]. 
  
Back to record